Company: HCTI
Filing Date: 2025-11-07
Form Type: PRE 14A
Source: 0001213900-25-107617
Chunk: 4

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-07
Form: PRE 14A
Chunk 4
---
 adjournment or postponement thereof. The Special Meeting will be held at 10:00 a.m.
Pacific Time at https://www.viewproxy.com/[●]sm/2025/[●].

On or about [●], 2025, we will commence
mailing of the proxy materials which are also available at https://www.viewproxy.com/[●]sm/2025/[●]. The proxy materials
are being sent to stockholders who owned our common stock at the close of business on November [●], 2025, the record date for the
special meeting (the “Record Date”). This Proxy Statement contains important information for you to consider when deciding
how to vote on the matters brought before the meeting. Please read it carefully.

Why am I receiving these materials?

| A. | We sent you this Proxy Statement because our Board is soliciting                                                                        
 your proxy to vote at the Special Meeting. This proxy statement summarizes the information you need to vote at the Special Meeting. You 
 do not need to attend the Special Meeting to vote your shares.                                                                          |

| Q. | What proposals will be voted on at the Special Meeting? |

| A. | Stockholders will vote on the following proposal at the Special 
 Meeting:                                                        |

| To consider and vote on a proposal to approve, for purposes                                                               
 of Nasdaq Listing Rule 5635(d), issuances of the Company’s securities that are completed during the period from [the date 
 of the Special Meeting] until three months thereafter that are in the aggregate up to $[50] million (“Future Issuances”), 
 as long as each Future Issuance is within the Nasdaq Parameters (as defined herein) (the “Nasdaq Approval Proposal”).     |

| We will also consider other business, if any, that properly comes before the Special Meeting. |

| Q. | How does our Board recommend that stockholders vote on the 
 proposals?                                                 |

| A. | Our Board recommends that stockholders vote “FOR” 
 the Nasdaq Proposal.                              |

| Q. | Who is entitled to vote? |

| A. | The                                                                                                                                
 record date for the Special Meeting is the close of business on November [●],                                                      
 2025. As of the Record Date, there were [●] shares of our common                                                                   
 stock, par value $0.00001 per share, and 20,000 shares of the Series A Super Voting Preferred Stock, par value $0.00001 per share